Total Payments
$791.74
2022 Payments
$26.42
Companies
15
Transactions
52
Medicare Patients
788
Medicare Billing
$39,348
Payment Breakdown by Category
Food & Beverage$786.74 (99.4%)
Education$5.00 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $786.74 | 51 | 99.4% |
| Education | $5.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie, Inc. | $173.38 | 12 | $0 (2018) |
| Genentech USA, Inc. | $138.90 | 8 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $135.12 | 9 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $60.42 | 5 | $0 (2017) |
| PFIZER INC. | $59.39 | 5 | $0 (2022) |
| GlaxoSmithKline, LLC. | $47.36 | 2 | $0 (2017) |
| Medtronic Vascular, Inc. | $37.00 | 2 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $29.73 | 2 | $0 (2017) |
| Mannkind Corporation | $20.39 | 1 | $0 (2017) |
| Novo Nordisk Inc | $20.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $26.42 | 2 | Genentech USA, Inc. ($14.64) |
| 2021 | $51.39 | 3 | Genentech USA, Inc. ($51.39) |
| 2020 | $48.81 | 3 | Genentech USA, Inc. ($37.11) |
| 2018 | $90.72 | 6 | AbbVie, Inc. ($28.48) |
| 2017 | $574.40 | 38 | AbbVie, Inc. ($144.90) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 2 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $5.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/06/2017 | AbbVie, Inc. | Androgel (Drug), Synthroid | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Endocrinology | ||||||
| 08/07/2017 | AbbVie, Inc. | Androgel (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Endocrinology | ||||||
| 08/01/2017 | Medtronic Vascular, Inc. | ClosureFast (Device), ClosureRFS, SilverHawk | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: EndoVenous Therapies | ||||||
| 07/28/2017 | Lilly USA, LLC | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Diabetes | ||||||
| 07/11/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/20/2017 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Endocrinology | ||||||
| 06/06/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/05/2017 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug), FARXIGA | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/23/2017 | Novartis Pharmaceuticals Corporation | FEVIPIPRANT (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| 05/22/2017 | AbbVie, Inc. | Androgel (Drug), Synthroid | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: Endocrinology | ||||||
| 05/17/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/02/2017 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2017 | AbbVie, Inc. | Androgel (Drug), Synthroid | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Endocrinology | ||||||
| 03/20/2017 | AbbVie, Inc. | Androgel (Drug) | Food and Beverage | In-kind items and services | $1.53 | General |
| Category: Endocrinology | ||||||
| 03/17/2017 | Medtronic Vascular, Inc. | ClosureFast (Device), Closure RFS, VenaSeal | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: EndoVenous Therapies | ||||||
| 03/01/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/01/2017 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Drug), ADACEL, FLUZONE | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: VACCINES | ||||||
| 02/27/2017 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: VACCINES | ||||||
| 02/23/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Immunology | ||||||
| 02/22/2017 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: DIABETES MEDICINE | ||||||
| 02/20/2017 | Merck Sharp & Dohme Corporation | ASMANEX (Drug), BELSOMRA, DULERA | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: RESPIRATORY | ||||||
| 01/27/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: RESPIRATORY | ||||||
| 01/27/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), ZOSTAVAX | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/25/2017 | Iroko Pharmaceuticals, LLC | VIVLODEX (Drug), TIVORBEX, ZORVOLEX | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: NSAID | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 370 | 371 | $79,558 | $22,527 |
| 2021 | 4 | 145 | 148 | $11,135 | $6,398 |
| 2020 | 6 | 273 | 286 | $18,172 | $10,422 |
Total Patients
788
Total Services
805
Medicare Billing
$39,348
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 224 | 225 | $43,650 | $13,067 | 29.9% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 31 | 31 | $12,462 | $4,087 | 32.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $8,820 | $2,392 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 20 | $5,680 | $2,068 | 36.4% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 20 | 20 | $1,980 | $628.11 | 31.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 12 | 12 | $6,696 | $196.25 | 2.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 27 | 27 | $270.00 | $88.66 | 32.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 93 | 95 | $8,919 | $5,358 | 60.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 17 | 17 | $1,942 | $886.85 | 45.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 14 | 15 | $227.41 | $106.49 | 46.8% |
| 81003 | Automated urinalysis test | Office | 2021 | 21 | 21 | $47.25 | $47.25 | 100.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 147 | 156 | $12,392 | $6,687 | 54.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 30 | 31 | $3,554 | $2,408 | 67.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 16 | 16 | $1,817 | $1,011 | 55.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 14 | 15 | $234.21 | $146.50 | 62.6% |
| 81003 | Automated urinalysis test | Office | 2020 | 48 | 50 | $115.38 | $111.80 | 96.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 18 | 18 | $59.04 | $58.48 | 99.1% |
About Dr. Daniel Bradford, M.D
Dr. Daniel Bradford, M.D is a Family Medicine healthcare provider based in Reno, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528123254.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Bradford, M.D has received a total of $791.74 in payments from pharmaceutical and medical device companies, with $26.42 received in 2022. These payments were reported across 52 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($786.74).
As a Medicare-enrolled provider, Bradford has provided services to 788 Medicare beneficiaries, totaling 805 services with total Medicare billing of $39,348. Data is available for 3 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Reno, NV
- Active Since 12/22/2006
- Last Updated 04/15/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1528123254
Products in Payments
- Androgel (Drug) $137.10
- FARXIGA (Drug) $86.62
- Avastin (Biological) $80.66
- BYDUREON (Drug) $48.50
- TECENTRIQ (Biological) $43.60
- ClosureFast (Device) $37.00
- XARELTO (Drug) $29.73
- ASMANEX (Drug) $25.40
- PREVNAR - 13 (Biological) $25.02
- ANORO (Drug) $24.32
- BOOSTRIX (Biological) $23.04
- JANUVIA (Drug) $21.27
- AFREZZA (Drug) $20.39
- Victoza (Drug) $20.00
- Humira (Biological) $19.71
- TRADJENTA (Drug) $17.26
- Synthroid (Drug) $16.57
- Alecensa (Biological) $14.64
- TOUJEO (Drug) $14.40
- FLUZONE HIGH-DOSE (Drug) $14.22
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Reno
Catherine Mccarthy, Md, MD
Family Medicine — Payments: $52,895
Family Medicine $52,895
Dr. Jeremy Bearfield, Md, Phd, MD, PHD
Family Medicine — Payments: $22,339
Family Medicine $22,339
Dr. Michael O'brien, Md, MD
Family Medicine — Payments: $22,320
Family Medicine $22,320
Dr. Vance Alm, Md, MD
Family Medicine — Payments: $18,168
Family Medicine $18,168
James Mclennan, Md Pc, MD PC
Family Medicine — Payments: $17,743
Family Medicine $17,743
Bayo Curry-Winchell, Md, MD
Family Medicine — Payments: $12,638
Family Medicine $12,638